BioCentury
ARTICLE | Management Tracks

Galapagos promotes Filius to president, Litchfield named Merck CFO; plus moves at LianBio, Adverum, Fulcrum, Aptose, Cyclerion, Medigene, Apie and more

March 25, 2021 4:16 AM UTC

Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) promoted Bart Filius to president from CFO while remaining COO. CEO Onno van de Stolpe will be responsible for oversight of R&D activities.

Caroline Litchfield will succeed Robert Davis as CFO of Merck & Co. Inc. (NYSE:MRK). As previously announced, Davis will become president of the pharma April 1 and succeed Kenneth Frazier as CEO on July 1. ...